Martingale Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Martingale Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-53,948	Closed	-$899K	–	1028
2017 Q4	$899K	Sell	53,948 -10,079	-16%	-$185K	0.01%	719
2017 Q3	$1.3M	Buy	+64,027	New	+$1.22M	0.02%	665
2015 Q3	–	Sell	-13,606	Closed	-$625K	–	917
2015 Q2	$625K	Sell	13,606 -40,413	-75%	-$1.92M	0.01%	648
2015 Q1	$2.53M	Sell	54,019 -2,500	-4%	-$99.5K	0.06%	296
2014 Q4	$1.79M	Sell	56,519 -13,848	-20%	-$405K	0.05%	348
2014 Q3	$1.67M	Sell	70,367 -30,267	-30%	-$775K	0.05%	332
2014 Q2	$3.02M	Buy	+100,634	New	+$2.71M	0.09%	240

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Martingale Asset Management's IPXL Position: Q1 2018 in Review

Martingale Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 53,948 shares — an estimated $899K sold.

Martingale Asset Management first reported a position in IPXL in Q2 2014 and held it in 7 quarters. The position peaked at $3.02M in Q2 2014. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

Martingale Asset Management reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
Martingale Asset Management sold 53,948 Impax Laboratories, Inc. shares in Q1 2018, an estimated $899K.
Martingale Asset Management first reported a position in Impax Laboratories, Inc. in Q2 2014 and held it in 7 quarters.
Martingale Asset Management's Impax Laboratories, Inc. position peaked at $3.02M in Q2 2014.
188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Martingale Asset Management's 13F filing for Q1 2018, filed 11 May 2018.